Buspirone Hydrochloride Tablet
Product Images NDC 63629-2414

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 63629-2414). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 mg ( Two Thirds Of A Tablet) (15mg 10mg)

FDA Label Image

15 mg (the Entire Tablet) (15mg 15mg)

FDA Label Image

5 mg (one Third Of A Tablet) (15mg 5mg)

FDA Label Image

7.5 Xxx (15mg 7 5)

FDA Label Image

10 mg (one Third Of A Tablet) (30mg 10mg)

FDA Label Image

15 mg Entire Tablet (30mg 15mg)

FDA Label Image

20 mg (two Thirds Of A Tablet) (30mg 20mg)

FDA Label Image

30 mg (the Entire Tablet) (30mg 30mg)

FDA Label Image

Break In Half (Break)

FDA Label Image

Label (Lbl636292414)

This is a description of a prescription medication called NILD, which is a type of buspirone hydrochloride tablet that is typically used for treating anxiety disorders. It contains 30 mg of USP buspirone hydrochloride and should be kept out of children's reach. The tablets should be stored between 20°C to 25°C (68°F to 77°F) in a tightly sealed, light-resistant container. It is available in 500 tablet quantities, as indicated by the last line of the text.*

FDA Label Image

Structural Formula (Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.